Funding Rounds

Triveni Bio

Triveni Bio October 2024 Series B Funding Round

Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.

View Company Profile

Summary

Stage: Series B

Raised Amount: $115.00M

Raised Date: 2024-10-02

Investors

Goldman Sachs Asset Management

Deep Track Capital

Fidelity Investments

Viking Global Investors
( 21 )

OrbiMed
( 34 )

Invus
( 33 )

Cormorant Asset Management